Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids ( DrugBank: Rituximab )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
85	特発性間質性肺炎	2

85. 特発性間質性肺炎

---

臨床試験数 : 627 /  薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01524068 (ClinicalTrials.gov)	September 2012	27/1/2012	A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations	A Multicenter, Open-Label, Phase II Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations	Idiopathic Pulmonary Fibrosis	Drug: Standard Steroid Treatment;Drug: The Standard Steroid Treatment, Plasma Exchange and rituximab	University of Pittsburgh	NULL	Withdrawn	18 Years	90 Years	Both	0	Phase 2	United States
2	NCT01266317 (ClinicalTrials.gov)	March 2011	22/12/2010	Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations	Open-Label, Feasibility Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations	IPF	Drug: Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids	Michael Donahoe	NULL	Completed	18 Years	80 Years	All	9	Phase 1/Phase 2	United States